Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

28.87
+0.93003.33%
Post-market: 29.060.1900+0.66%16:15 EDT
Volume:5.21M
Turnover:146.71M
Market Cap:3.24B
PE:-25.03
High:29.02
Open:27.48
Low:27.06
Close:27.94
Loading ...

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Motley Fool
·
Yesterday

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Motley Fool
·
Yesterday

Why Viking Therapeutics Stock Popped Again Today

Motley Fool
·
Yesterday

Cantor Fitzgerald Initiates Viking Therapeutics at Overweight With $104 Price Target

MT Newswires Live
·
29 Apr

Viking Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
29 Apr

Viking Therapeutics Price Target Cut to $75.00/Share From $95.00 by Truist Securities

Dow Jones
·
28 Apr

Viking Therapeutics price target lowered to $75 from $95 at Truist

TIPRANKS
·
28 Apr

Viking Therapeutics Inc : Truist Securities Cuts Target Price to $75 From $95

THOMSON REUTERS
·
28 Apr

Truist Securities Cuts Viking Therapeutics Price Target to $75 From $95, Maintains Buy Rating

MT Newswires Live
·
25 Apr

Viking Therapeutics: Promising Pipeline and Strategic Execution Drive Buy Rating

TIPRANKS
·
25 Apr

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025

Simply Wall St.
·
25 Apr

Viking Therapeutics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
25 Apr

Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?

Zacks
·
24 Apr

Viking Therapeutics price target lowered to $85 from $96 at B. Riley

TIPRANKS
·
24 Apr

B. Riley Adjusts Price Target on Viking Therapeutics to $85 From $96, Maintains Buy Rating

MT Newswires Live
·
24 Apr

Q1 2025 Viking Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
24 Apr

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

Zacks
·
24 Apr

Viking Therapeutics: Strong Financials and Promising VK2735 Program Drive Buy Rating

TIPRANKS
·
24 Apr

Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

GuruFocus.com
·
24 Apr

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying

Insider Monkey
·
24 Apr